Peter Loffelhardt, Founder and CEO of Global MPN Scientific Foundation, shared a post on LinkedIn:
” Exclusive ASH2024 Insights from Prof. Ruben Mesa and Prof. Srdan Verstovsek!
This week, I had the honor of moderating an insightful discussion with two of the world’s leading experts in MPN research. Together, we explored the latest advancements and breakthroughs shaping the future of MPN care.
This session offered valuable perspectives for patients, caregivers, and healthcare professionals alike. Don’t miss the opportunity to gain exclusive insights into what’s ahead for MPN treatment and management.
Watch the full video now.”